Thailand IVF Full Process Guide: Complete Step-by-Step Analysis from Examination to Transfer
Opening: Real Consultation Scenario
In a reproductive clinic, a 42-year-old female patient holding an AMH 0.6 report asked, "Doctor, for my situation, what is the process for doing IVF in Thailand, and how long will it take?" This is a common decision-making issue for people with diminished ovarian reserve. The full Thailand IVF process is divided into five core stages, each with specific time requirements and precautions. This article analyzes the complete process from a clinical perspective, helping patients establish a clear understanding of the cycle.
I. Thailand IVF Complete Process Framework
From initiation to completion, Thailand IVF typically includes the following five stages. The total cycle duration varies due to individual differences, generally ranging from 2 to 3 months.
| Stage | Main Content | Approximate Duration |
|---|---|---|
| Preliminary Examination & Preparation | Fertility assessment for both partners, infectious disease screening, chromosome analysis, document processing | 1-2 months |
| Ovarian Stimulation | Use of stimulation medications to promote follicle development, monitoring follicle growth | 10-14 days |
| Egg Retrieval, Sperm Collection & Embryo Culture | Transvaginal ultrasound-guided egg retrieval, sperm optimization, in vitro fertilization, blastocyst culture | 5-7 days |
| PGT Screening (Optional) | Chromosomal screening of blastocysts to select normal embryos | 14-21 days |
| Transfer & Luteal Phase Support | Endometrial preparation, blastocyst transfer, post-transfer luteal support, pregnancy test | Approximately 1 month |
If a frozen embryo transfer is used, the examination and stimulation are completed in one cycle, and the transfer occurs in a subsequent cycle. The waiting period for PGT screening results can be spent back home; there is no need to stay in Thailand.
II. Preliminary Examination & Preparation Stage
Required Examination Items
Female Examinations:
- Basic Endocrine Panel Six: FSH, LH, E2, P, T, PRL (blood draw on days 2-4 of menstruation)
- AMH (Anti-Müllerian Hormone): Assesses ovarian reserve, can be checked anytime
- Transvaginal Ultrasound: Antral Follicle Count (AFC), completed on days 2-4 of menstruation
- Infectious Disease Screening: Hepatitis B, Hepatitis C, HIV, Syphilis (valid for 3-6 months)
- Chromosome Karyotype Analysis: Results take 10-14 business days
- Thyroid Function: TSH, FT3, FT4
- Uterine Cavity Examination: If there is a history of uterine surgery, endometrial polyps, or abnormal uterine bleeding, hysteroscopy evaluation is recommended.
Male Examinations:
- Semen Analysis: Routine parameters + Morphology + DNA Fragmentation Index (abstinence for 2-7 days)
- Infectious Disease Screening: Same as for female
- Chromosome Karyotype Analysis: Same as for female
Differences in Examinations by Age Group
For women over 35, it is recommended to increase the frequency of ovarian reserve assessment, rechecking AMH and antral follicle count every 3-6 months. For women over 40, in addition to routine examinations, genetic counseling and uterine cavity evaluation are recommended, and endometrial receptivity testing may be added if necessary. If the male partner is over 40, sperm DNA fragmentation testing is recommended; a fragmentation rate above 30% may affect blastocyst formation rate and pregnancy outcomes.
Easiest Detail to Overlook: Document Preparation
Thailand IVF requires a passport and a medical visa. The passport must be valid for more than 6 months. It is advisable to check the passport's validity in advance and renew it early if it is about to expire. The medical visa requires a hospital invitation letter, a medical plan, and round-trip flight booking confirmation. It is recommended to complete document preparation one month before starting ovarian stimulation.
Low AMH does not mean there is no chance, but expectations need to be realistic. AMH < 0.4 indicates severe depletion, usually resulting in fewer than 3 eggs retrieved, with a higher risk of attrition during embryo culture and PGT screening. For such individuals, it is recommended to start conditioning 3-6 months in advance, including supplementation with Coenzyme Q10, Vitamin D, and, under a doctor's guidance, DHEA if necessary.
Examination Timeline Planning: AMH, FSH, and antral follicle count need to be completed on days 2-4 of menstruation. Semen analysis requires 2-7 days of abstinence. Chromosome analysis results usually take 10-14 business days. Infectious disease screening results are valid for 3-6 months; it is recommended to complete them within one month before the planned start to avoid needing a retest due to expiration.
III. Ovarian Stimulation Stage
Doctor's Decision Logic: How to Choose a Stimulation Protocol?
The choice of ovarian stimulation protocol depends on the patient's ovarian reserve, age, BMI, previous stimulation history, and the presence of specific conditions (such as Polycystic Ovary Syndrome, Endometriosis).
- Antagonist Protocol: Suitable for most people, short cycle, fewer side effects, ideal for patients with normal ovarian reserve (AMH > 1.2, AFC > 8).
- Mild Stimulation Protocol: Suitable for patients with diminished ovarian reserve (AMH 0.5-1.2, AFC 4-8) to reduce medication dosage and cycle cancellation rates.
- PPOS Protocol: Suitable for patients with significantly diminished ovarian reserve or high LH levels, using progesterone to suppress premature LH surge and improve follicle utilization.
- Ultra-Long Protocol: Suitable for patients with endometriosis or adenomyosis, first using GnRH agonist to suppress lesions before starting stimulation.
Ovarian Stimulation Process & Timeline
Ovarian stimulation typically takes 10-14 days. Daily injections of stimulation medications start from days 2-4 of menstruation, with monitoring of follicle growth and hormone levels every 2-3 days. When the leading follicles reach 18-22mm in diameter, an HCG or GnRH trigger is administered, and egg retrieval takes place 36 hours later.
What to Watch Out For: During stimulation, avoid strenuous exercise and sudden changes in body position to prevent ovarian torsion. Diet should focus on high protein, easy-to-digest foods, and drink plenty of water. If symptoms like bloating, nausea, or decreased urination occur, inform the doctor promptly to assess the risk of OHSS.
IV. Egg Retrieval, Sperm Collection & Embryo Culture
Actual Process
Egg retrieval is performed under intravenous anesthesia, using transvaginal ultrasound-guided follicle aspiration. The procedure takes about 15-30 minutes. After a 1-2 hour observation period, the patient can leave if there are no issues. The male partner provides a semen sample on the day of retrieval; if collection is difficult, a backup frozen sample can be prepared in advance.
Eggs and sperm are combined in the laboratory, and culture to the blastocyst stage typically takes 5-6 days. Blastocyst culture requires high laboratory standards, including stable temperature, humidity, gas environment, and high-quality culture media.
Easiest Details to Overlook
- Mild bloating and slight vaginal bleeding after retrieval are normal. If severe abdominal pain, heavy bleeding, or difficulty breathing occurs, seek medical attention immediately.
- Blastocyst culture carries a risk of attrition. Patients with a low number of retrieved eggs should be aware of this and prepare mentally in advance.
- Laboratory quality directly affects the blastocyst formation rate. When choosing a medical institution, pay attention to its laboratory qualifications and historical data.
Decision Point for Embryo Culture: When is blastocyst culture suitable? When there are enough follicles (≥ 6 mature eggs), a history of successful blastocyst culture, or when PGT screening is needed. When is it not recommended? When the number of eggs retrieved is very low (≤ 3), or when all previous blastocyst cultures have failed; cleavage-stage transfer may be considered.
V. PGT Screening Stage
PGT (Preimplantation Genetic Testing) is an important optional step in the Thailand IVF process. PGT-A screens for chromosomal aneuploidy, and PGT-M detects single gene disorders.
When is PGT Suitable?
- Female age ≥ 38 years
- Recurrent pregnancy loss (≥ 2 times)
- Repeated implantation failure (≥ 3 transfers of good quality embryos without pregnancy)
- Known chromosomal abnormalities (e.g., balanced translocation, Robertsonian translocation)
- Family history of single gene disorders
When is it Not Suitable?
When the number of embryos is low (e.g., only 1-2 blastocysts), the potential loss of embryos due to PGT screening needs to be weighed. PGT screening carries a minimal risk of damage to the embryo, but overall safety is high. Transfer of chromosomally normal embryos does not guarantee pregnancy; PGT cannot completely ensure a pregnancy outcome.
Process & Timeline: PGT screening results take 14-21 days. Screened embryos are cryopreserved and transferred in a subsequent cycle. Patients can return home during the waiting period; there is no need to stay in Thailand.
VI. Transfer & Luteal Phase Support
Transfer Process
The transfer cycle requires endometrial preparation. Common protocols include:
- Natural Cycle: Suitable for patients with regular menstruation and normal ovulation. Follicles and endometrium are monitored, and transfer is scheduled after ovulation.
- Artificial Cycle: Suitable for patients with irregular menstruation or those needing flexible transfer timing. Estrogen is used to prepare the endometrium, and progesterone is used for endometrial transformation before transfer.
- Stimulated Cycle: Used in a few specific situations, using stimulation medications to improve endometrial receptivity.
Transfer is scheduled when the endometrial thickness reaches 7-12mm with good morphology. The transfer procedure is painless, performed under ultrasound guidance to place the embryo into the uterine cavity. The patient rests in bed for 30 minutes afterward.
Luteal Phase Support
Luteal phase support is required after transfer. Common medications include progesterone injections, vaginal sustained-release gel, or oral preparations. Luteal support continues until 10-12 weeks after transfer (when the placenta forms).
How to Determine if Transfer is Successful
A blood test for HCG is done 12-14 days after transfer to determine biochemical pregnancy. An ultrasound at 4-5 weeks after transfer confirms clinical pregnancy (visible gestational sac and fetal heartbeat).
Prolonged bed rest is not necessary. Resume normal activities after transfer, avoiding strenuous exercise and heavy lifting. Prolonged bed rest is not conducive to blood circulation and increases the risk of thrombosis.
VII. Differences Across Age Groups
Age is a core factor influencing IVF outcomes, and the focus of the process differs across age groups.
| Age Group | Process Focus | Special Considerations |
|---|---|---|
| < 35 years | Routine examination + Antagonist protocol + Blastocyst culture | Ovarian reserve is usually normal; pay attention to preventing OHSS |
| 35-39 years | Enhanced ovarian reserve assessment + PGT screening recommendation | Miscarriage rate increases with age; PGT can reduce the risk of miscarriage |
| ≥ 40 years | Genetic counseling + Uterine cavity evaluation + Mild stimulation protocol | Number of eggs retrieved decreases, embryo aneuploidy rate increases; early conditioning recommended |
VIII. Total Timeline Planning Suggestions
Based on the above process, the complete Thailand IVF cycle timeline is planned as follows:
- Examination & Preparation Stage: Complete all examinations and document processing 1-2 months in advance.
- Ovarian Stimulation & Egg Retrieval Stage: Stay in Thailand for approximately 14-18 days (including stimulation and post-retrieval observation).
- Embryo Culture & PGT: If doing PGT, wait 14-21 days for results; can wait back home.
- Transfer Stage: For frozen embryo transfer, travel to Thailand again for about 10-14 days.
For older individuals or those with low AMH, it is recommended to start conditioning and examinations 3-6 months in advance. Conditioning includes supplementation with Coenzyme Q10, Vitamin D, DHEA (under doctor's guidance), improving lifestyle, weight control, and smoking cessation and alcohol limitation.
Timeline Planning Reminder:
The total time for Thailand IVF varies per person. The key lies in the completeness of preliminary examinations, the ovarian response to stimulation medications, and the embryo screening results. It is advisable to allow sufficient time flexibility to avoid time pressure affecting medical decisions. It is not recommended to start preparing for examinations only one month before stimulation, as abnormal results may require retesting or treatment, leading to cycle delays.
IX. Common Risks & Precautions
- Ovarian Hyperstimulation Syndrome (OHSS): Symptoms like bloating, nausea, and decreased urination after stimulation. Mild cases resolve on their own; severe cases require medical intervention.
- Egg Retrieval Surgery Risks: Bleeding, infection, ovarian torsion, etc., are low in incidence but require choosing a reputable medical institution.
- Embryo Culture Failure: Egg quality, sperm quality, and laboratory conditions all affect blastocyst formation; reasonable psychological expectations are necessary.
- PGT Screening Attrition: Some embryos may be discarded due to chromosomal abnormalities; the fewer the embryos, the greater the impact of attrition.
- Transfer Failure: Even chromosomally normal embryos may not result in pregnancy after transfer, related to endometrial receptivity, immune factors, etc.
Practitioner's Observation: In the Thailand IVF process, the completeness of preliminary examinations and timeline planning are most often underestimated. Many patients focus on the stimulation and transfer stages, overlooking the impact of the examination phase on the overall cycle. Waiting for chromosome results, retesting due to expired infectious disease screenings, and renewing expiring passports – these details can all cause delays. It is recommended to prepare a checklist two months before starting and complete each item systematically.
This content is for medical knowledge reference only and does not constitute medical advice. Specific treatment plans should be developed by a reproductive specialist based on individual circumstances.
